Business
Wearable Devices Receives Approval for $750,000 Budget for Neurorehabilitation Pilot with Soroka Medical Center
The non-dilutive grant for the program was provided by the Israel Innovation Authority YOKNEAM ILLIT, ISRAEL, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Wearable
About this update from Wearable Devices Ltd.
[{"type":"text","content":"The non-dilutive grant for the program was provided by the Israel Innovation Authority YOKNEAM ILLIT, ISRAEL, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (Nasdaq: WLDS, WLDSW) (“Wearable Devices” or the “Company”), a technology growth company specializing in AI-powered touchless sensing wearables, today announced it has received a grant approval from the Israel Innovation Authority (“IIA”) for a total budget of $750,000 to finance a clinical pilot program in partnership with Soroka University Medical Center (“Soroka Hospital”). The pilot program will seek to validate the Company’s Mudra Link neural wristband as a rehabilitation tool for patients suffering from impaired grip-force control following motor-cortex brain injuries. Utilizing patented surface neural ElectroMyography (“EMG”) technology, the system provides real-time, objective biofeedback to train modulation, anticipation, and correction of grip force. The pilot program highlights the broader applicability of the Mudra technology stack, extending its proven EMG capabilities into monitoring domains that naturally complement the Company’s existing work in neural interaction. “Rehabilitation and assistive technologies were always the first go-to market of Brain Computer Interface companies where the willingness to adopt new life changing solutions is naturally high,” said Guy Wagner, President and Chief Scientific Officer of Wearable Devices. “The Mudra platform is uniquely positioned to deliver quantifiable, engaging, and cost-effective therapy that can be performed at home with minimal therapist supervision and at much lower costs than currently available solutions. This pilot at Soroka Hospital, backed by the IIA, is a critical next step on the path toward establishing Mudra as the standard of care in grip-force neurorehabilitation worldwide.” Dr. Salman Zubedat, research and development and clinical applications scientist who is leading the clinical pilot on behalf of Wearable Devices, commented: “The current standard of care in force-control rehabilitation is often subjective, relying on improvised methods without consistent, quantitative performance tracking. Our pilot with Soroka Hospital represents a crucial scientific step toward clinical validation. By leveraging the Mudra Link’s non-invasive ability to capture objective, quantitative neuro-muscular d...